# Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds

> **NCT01772303** · EARLY_PHASE1 · UNKNOWN · sponsor: **HealOr** · enrollment: 100 (estimated)

## Conditions studied

- Hard to Heal Wounds

## Interventions

- **DRUG:** HO/03/03 10-40 µg

## Key facts

- **NCT ID:** NCT01772303
- **Lead sponsor:** HealOr
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2013-08
- **Final completion:** 2013-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772303, "Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01772303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*